Alzheimer's disease [NEW TOPIC PAGE]

Main|Search|PHGKB




Last Posted: Mar 19, 2020

---

• "Choosing Wisely": Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer's Disease in Dementia Clinics.
  Yang Hyun Ju et al. Journal of Alzheimer's disease : JAD 2020 Mar
• A machine learning-based linguistic battery for diagnosing mild cognitive impairment due to Alzheimer's disease.
  Orimaye Sylvester Olubolu et al. PloS one 2020 15(3) e0229460
• Another step forward in blood-based diagnostics for Alzheimer’s disease
  RJ Bateman et al, Nature Medicine, March 4, 2020
• Sex and APOE ε4 genotype modify the Alzheimer’s disease serum metabolome
  M Arnold, Nature Communications, March 2, 2020
• Issues and Questions Surrounding Screening for Cognitive Impairment in Older Patients.
  Petersen Ronald C et al. JAMA 2020 Feb (8) 722-724
• [Direct-to-consumer genetic tests in the consulting room].
  Gerrits Elianne M et al. Nederlands tijdschrift voor geneeskunde 2019 Nov 163
• Assessment of Demographic, Genetic, and Imaging Variables Associated With Brain Resilience and Cognitive Resilience to Pathological Tau in Patients With Alzheimer Disease.
  Ossenkoppele Rik et al. JAMA neurology 2020 Feb
• Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning.
  Franzmeier Nicolai et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2020 Feb
• Alzheimer's disease susceptibility gene apolipoprotein e (APOE) and blood biomarkers in UK Biobank (N=395,769).
  A Ferguson et al, MedRXIV, Februray 13, 2020
• Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease1,2.
  Ezzati Ali et al. Journal of Alzheimer's disease : JAD 2020 Jan

more